#AJD Pioglitazone ban is controversial Doctors in India have shown their concern following unexpected decision by the Government to suspend the sales of pioglitazone (pio) . The Government suspended the manufacture, sale and distribution of pio at the end of June citing the concerns for adverse effects, particularly, bladder cancer according to a report published in BMJ. The doctors in the country feel that it should not have been banned.emedinews.blogspot.in/2013/07/pioglitazone-ban-is-controversial.html
Posted on: Thu, 11 Jul 2013 16:34:44 +0000
Trending Topics
Recently Viewed Topics
© 2015